PG2311-PJT6970-COL018834-CEIVD-COVID-Flu-Banners-Older-woman-F-270x195

Viruses take lives. Early, accurate detection and differentiation is the first step to proper treatment.

The arrival of COVID-19 into the ecosystem changed the way we approach respiratory testing. Gone are the days or relying on a rapid test to diagnose an infection. PCR or molecular testing is now the gold standard. Its magnifying capacity allows laboratorians to detect the virus, even when there are minimal copies in the host

Request more information

Features of the TaqPath COVID-19, Flu A, Flu B Combo Kit

  • Single test for SARS-CoV-2, influenza A, and influenza B
    • Simultaneously differentiates respiratory diseases
    • Helps identify cases of co-infection
  • Affordable and scalable
    • Increases testing throughput and lab efficiency
  • Sensitive and specific RT-PCR detection
    • Robust performance for detecting SARS-CoV-2, flu A and flu B
  • Results automated by Applied Biosystems Pathogen Interpretive Software
    • Quickly interprets results to expedite reporting
    • Helps reduce risk of user interpretation error
TaqPath-COVID19-Flu-Kit_EUA
flu-season-woman-sneezing

Blog: Differentiating multiple respiratory viruses with a single test

Read the blog

Product details

Targets

  • SARS-CoV-2 (S gene and N gene)
  • Influenza A (matrix gene)
  • Influenza B (matrix gene)

Internal control

  • MS2 phage control

Authorized sample types

  • Nasopharyngeal (NP) swab
  • Anterior nasal (nasal) swab

Authorized sample preparation

Authorized instruments

Limit of detection (LOD)

  • SARS-CoV-2: 100 GCE/mL
  • Influenza A: 200–500 GCE/mL
  • Influenza B: 500–1,000 GCE/mL

Solution workflow

Turnaround time from sample to interpreted results is approximately 3 hours. The required workflow consists of sample extraction and preparation, real-time RT-PCR genetic analysis, and automated translation of data into patient diagnosis.

FluEUAWorkflow

Simple analysis and reporting

PI EUA Splash Without Version

The Applied Biosystems Pathogen Interpretive Software EUA Edition is part of the required workflow and must be downloaded prior to instrumentation use.

You may download the software upon kit purchase. Labs following the authorized workflow are required to complete an eLearning course and pass an exam to download.

Follow the instructions below to obtain the software from your local support team:

  • Go to thermofisher.com/contactus
  • Select “Instrument Service” as category
  • Enter product name or Cat. No. and select your country
  • Call the local number displayed on the screen

Ordering information

Product

Included component

Qty

Cat. No.

TaqPath COVID-19, Flu A, Flu B Combo Kit

TaqPath COVID-19, Flu A, Flu B RT-PCR Assay (1 tube)

1,000 rxns

A49868

MS2 Phage Control (10 tubes)

TaqPath COVID-19, Flu A, Flu B Control Kit (10 tubes)

TaqPath COVID-19 Control Dilution Buffer (10 tubes)

Find your IFU

Find the approved Instructions for Use (IFU) for your country. (Note: Product availability varies by country.)

Find out more ›


Looking for additional respiratory viral targets?

Learn more

Resources

For Emergency Use Authorization (EUA) Only. For prescription use only. For in vitro diagnostic use. Product availability varies by country.